Can a vitamin and walking lower blood pressure in menopause?
NCT ID NCT07475208
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether taking a vitamin B3-like supplement (nicotinamide riboside) combined with brisk walking twice a week can lower blood pressure in post-menopausal women with early-stage hypertension. 112 women will be randomly assigned to one of four groups: supplement plus walking, supplement only, walking only, or placebo. The trial lasts 10 weeks and measures blood pressure and blood markers of vascular health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nicotinamide riboside (a form of vitamin B3) and brisk walking
What this could lead to
If it works, this could point toward a simple, non-drug way to help post-menopausal women manage early high blood pressure.
What could go wrong
This is a small, early-stage trial with no phase designation, so results may not be conclusive. The combination may not lower blood pressure more than exercise alone, and individual responses can vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION (HTN) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.